Cardiac Alarmins as Residual Risk Markers of Atherosclerosis under Hypolipidemic Therapy
Increased levels of low-density lipoproteins are the main risk factor in the initiation and progression of atherosclerosis. Although statin treatment can effectively lower these levels, there is still a residual risk of cardiovascular events. We hypothesize that a specific panel of stress-sensing mo...
Main Authors: | Viorel I. Suica, Elena Uyy, Luminita Ivan, Raluca M. Boteanu, Aurel Cerveanu-Hogas, Rune Hansen, Felicia Antohe |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/19/11174 |
Similar Items
-
Short-Term Blockade of Pro-Inflammatory Alarmin S100A9 Favorably Modulates Left Ventricle Proteome and Related Signaling Pathways Involved in Post-Myocardial Infarction Recovery
by: Raluca Maria Boteanu, et al.
Published: (2022-05-01) -
Exosome Proteomics Reveals the Deregulation of Coagulation, Complement and Lipid Metabolism Proteins in Gestational Diabetes Mellitus
by: Elena G. Bernea, et al.
Published: (2022-08-01) -
Involvement of Alarmins in the Pathogenesis and Progression of Multiple Myeloma
by: Giuseppe Murdaca, et al.
Published: (2021-08-01) -
Schizophrenia and Alarmins
by: Huan Ma, et al.
Published: (2022-05-01) -
Role of Alarmins in the Pathogenesis of Systemic Sclerosis
by: Antonello Giovannetti, et al.
Published: (2020-07-01)